Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded in 2020, Rose Health Ventures is a venture capital firm based in the United States. The firm focuses on early-stage investments in healthcare, biotech, and digital health, with a portfolio of three companies. Their typical check size is $1 million, and they emphasize support for female and minority-owned businesses.
Rose Health Ventures invests in sectors related to Cancer, Heart Disease, and Mental Health. They primarily write checks of $1 million to pre-seed and seed stage companies, targeting entrepreneurs who leverage deep technology and science to improve health outcomes.
Notable companies in their portfolio include Rose Health, which provides an end-to-end care experience for mental health; OxiWear, a wearable device for continuous blood oxygen monitoring; and Hibiscus Health, which offers resources to prevent type 2 diabetes.
The team includes experienced healthcare executives from institutions like HCA Healthcare, Johns Hopkins Hospital, Mayo Clinic, Cleveland Clinic, Mass General, Charité-Universitätsmedizin Berlin, and Sheba Medical Center.
Submit your pitch through their website contact form for consideration.
Yes, Rose Health Ventures often leads investment rounds, particularly in their focus areas of healthcare and biotech.
The firm is open to follow-on investments, especially for companies that align with their mission and demonstrate strong growth potential.
While specific fund size details are not disclosed, the firm typically invests $1 million in early-stage companies.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.